Tag: ART

SKYSCRAPER-06 evaluating tiragolumab plus Tecentriq and chemotherapy did not meet the primary endpoints of progression-free survival at primary analysis and ...

Aggregated presentation by day and by market Purchases of own shares from June 24th to 28th 2024       Name of the IssuerIdentity ...

REDWOOD CITY, Calif.—June 20, 2024—Helm.ai, a leading provider of advanced AI software for high-end ADAS, Level 4 autonomous driving, and ...

BINZHOU, China, June 18, 2024 (GLOBE NEWSWIRE) -- A media team invited by Binzhou Municipal Government Information Office visited the Shandong Sea ...

Aggregated presentation by day and by market Statement of transactions in own shares from June 3 to June 7, 2024                          ...

The Belgian Meat Office is pleased to announce the return of its "The Art of European Pork: By the Belgian ...

DUBAI, United Arab Emirates, May 22, 2024 (GLOBE NEWSWIRE) -- On May 18, 2024, MetaHomes was honored to participate in ...

LOS ANGELES, May 01, 2024 (GLOBE NEWSWIRE) -- JAPAN HOUSE Los Angeles is pleased to announce the opening of “Yes, ...

VENICE, Italy, April 17, 2024 (GLOBE NEWSWIRE) -- Wadi AlFann presents Journeys in Land Art, Towards Wadi AlFann, AlUla, a ...

Columvi, in combination with chemotherapy, demonstrated a statistically significant improvement in overall survival for people with relapsed or refractory diffuse ...